Our postdoctoral researcher, Metin, has been awarded the prestigious Hollings Postdoctoral Fellowship —a well-deserved recognition of his outstanding work.
Categories: News
See the latest news about our lab!
“Hollings team marks milestone in progress toward investigational new drug for triple-negative breast cancer” https://hollingscancercenter.musc.edu/news/archive/2024/07/22/lox-inhibitor-for-triple-negative-breast-cancer
0 Comments